Research

Two faculty members in the School of Molecular & Cellular Biology have been selected as Emerging Research Leaders by the University of Illinois Interdisciplinary Health Sciences Institute. 

CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests. The researchers successfully deployed CAR-T in a mouse model of ovarian cancer, a type of aggressive, solid-tumor...

Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.

Through a new approach of cross-linking cell proteins directly to a protein of interest, researchers at the University of Illinois Urbana-Champaign’s School of Molecular & Cellular Biology have distinguished new patterns of cell interactions with a molecular chaperone.  

In recognition of his work, Dr. Vipendra Kumar was recently awarded a fellowship from the FRAXA Research Foundation, whose mission is to discover better treatments and ultimately cure the genetic disorder Fragile X Syndrome.

Researchers at the Beckman Institute for Advanced Science and Technology found that early exposure to an environmental chemical called polychlorinated biphenyls, or PCBs, made it more difficult for mice to recover from sound-related trauma sustained later in life.

Researchers at the Beckman Institute for Advanced Science and Technology used deep learning to develop a new framework for super-resolution ultrasound.

Thomas Kehl-Fie, a professor of microbiology in the School of Molecular & Cellular Biology, and collaborator Kevin Waldron, a professor at the Institute of Biochemistry & Biophysics in Warsaw, Poland, have found that have found that in response to the immune system restricting metal...

New research from University of Illinois biochemistry professor Raven Huang reveals that lethal ribosomal damage in bacteria can be reversed by a pair of bacterial enzymes named PrfH and RtcB. The finding raises the question of whether similar ribosomal damage can also be repaired in humans because...

The Cancer Center at Illinois is proud to announce the selection of nine interdisciplinary cancer research projects, involving multiple MCB faculty members, designed by University of Illinois Urbana-Champaign faculty to be funded by Cancer Center at Illinois (CCIL) developmental grant awards.